Donate $125 and receive a beautiful hand-made glass molecule.
(Choose from molecules such as DMT, Nitrous Oxide, or MDMA).


Ibogaine Basics
by Erowid




IBOGAINE IMAGES
DESCRIPTION
Ibogaine is a hallucinogenic chemical that can cause profound and long-lasting hallucinations. In its pure form, it is a white, bitter-tasting powder. It occurs naturally in a number of plants native to West Central Africa, including Tabernanthe iboga and Voacanga africana. Ibogaine-containing plants have a history of traditional use in West Africa in initiation ceremonies and religious rituals. Though there has been limited interest in ibogaine as a recreational psychoactive due in part to its long duration of action, Ibogaine has received attention in Europe and the U.S. since the 1960s as an anti-addiction therapy especially for the treatment of opiate addiction.
[ Main Ibogaine Vault ]

Dose
When ingested in traditional religious ceremonies, ibogaine doses are highly variable. In TiHKAL, Shulgin and Shulgin describe typical doses of pure ibogaine HCl as "at or above 1000 milligrams", but also describe profound effects at 200 mg, orally. In the Manual for Ibogaine Therapy, Lotsof and Wachtel recommend 15-20 mg/kg for opiate addiction treatment. An ibogaine clinic reports administering a dose of 16-22 mg/kg. Note: Pure ibogaine dosages are much smaller than those of iboga powder, which is around 1% psychoactive alkaloids by mass.

Price
Ibogaine is rarely found on the black market for recreational use.

Law
Ibogaine is illegal to possess and sell in the United States (Schedule I) and in several other countries. It became a regulated substance in the U.S. in 1967.

Chemistry
The chemical name for ibogaine is 12-Methoxyibogamine (C20H26N2O). It is a naturally occurring indole alkaloid in the tryptamine family.

Pharmacology
Ibogaine is slowly metabolized by the liver into noribogaine and other metabolites, some of which may be psychoactive. Ibogaine acts on numerous receptor systems, including the dopaminergic, serotonergic, nicotinic, GABA, and muscarinic systems. Some studies have found evidence that ibogaine may interrupt the mechanisms of opiate dependence.

Production
Ibogaine is generally extracted from plant material, but may also be synthesized.

History
The T. iboga plant has been used ritually in Africa since at least the nineteenth century, perhaps much earlier. There are several contemporary iboga churches such as the Bwiti which use iboga as a sacrament and initiation tool. Ibogaine was first extracted from T. iboga in 1901. An ibogaine-containing extract was sold as an antidepressant called Lambarene in France beginning in 1939. During the 1960s ibogaine was briefly investigated as adjunct to psychedelic therapy. In the last few decades there has been continuing interest in Europe, North America, and Mexico in the use of ibogaine for addiction therapy.

Effects
Onset
When taken orally, the effects of ibogaine usually begin within 45 minutes to three hours.

Duration
The most intense effects of ibogaine may last 24 hours or more, during which time a user may be immobilized. After-effects may last an additional day or two.

The Experience
When taken in a strong dose, ibogaine often causes nausea and vomiting which may be followed by numbness of skin, mild auditory and dreamlike visual hallucinations lasting for 3-4 hours. This is frequently followed by an intense autobiographical inventory of the events and significance of one's life, lasting from 8-20 hours. Lingering physical effects such as difficulty sleeping may persist for an additional day or two.

PROBLEMS
Several deaths have resulted directly from ibogaine ingestion. Users frequently experience extreme nausea. Depending on dose, users may be incapacitated and/or immobilized for many hours. High doses (beginning at 75-100 mg/kg) have been shown to have neurotoxic effects in rats and non-human primates, although therapeutic doses may not be neurotoxic.
Deaths
There are several known fatalities due to ibogaine use. Some deaths have occurred in clinical or quasi-clinical environments. A 40-year-old woman died of heart failure after being administered 8 mg/kg in a psychotherapy session. In 2006, a 38-year-old man died of pulmonary thrombosis during ibogaine addiction treatment at a clinic in Tijuana, Mexico. Traditional iboga use is reported by some West Africans to be occassionally fatal, and there is at least one documented case of a fatality following ingestion of iboga root bark.

Addiction Potential
Ibogaine is not believed to be addictive, and is very unlikely to result in psychological or physical dependency.

Contraindications


Last Modified - Mon, Jul 14, 2008 Created by Erowid 7/15/08

[ Back to Ibogaine Vault ] [ Back to Psychoactive Chemical Vaults ]
[Plants & Drugs] [Mind & Spirit] [Freedom & Law] [Arts & Sciences] [Library] [Search] [About]
(content and html © 1995-2008 Erowid.org. Please ask permission before publicly reproducing.)
Erowid.org Plants & Drugs Mind & Spirit Freedom & Law Arts & Sciences Search About Erowid and Feedback Library & Bookstore Copyrights Memberships